Skip to main content

Show 54 results Show all

DMPA-SC Advocacy Pack

Tools for advocacy and communications to increase contraceptive access and options

DMPA-SC is transforming contraceptive access, use, and choice for women and adolescent girls. Advocates play an important role in making sure their country’s policies and funding support access to a broad method mix, including options like DMPA-SC and self-injection.

The Injectable Access Collaborative’s DMPA-SC Advocacy Pack is designed to accelerate your advocacy efforts. It consists of evidence-based materials for advocates to use both for their own strategy development and for direct advocacy with decision-makers. Available in English and French in PDF, Word, and PowerPoint formats, materials are customizable and unbranded so that you can tailor them to your country context. Advocacy Pack for Subcutaneous DMPA. Product brand name Sayana Press.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: December, 2023

Slide template: Expanding options and access with DMPA-SC

This customizable slide deck template from the DMPA-SC Advocacy Pack provides a brief description of DMPA-SC and its benefits; an overview of evidence on how the product expands access through multiple delivery channels; and illustrative policy and advocacy gaps and recommendations for country decision-makers. Available in PowerPoint and PDF formats.

Institutional author(s): PATH
Publication date: 2023

The case for DMPA-SC

Using simple messages, this DMPA-SC Advocacy Pack case statement describes reasons why DMPA-SC is a valuable and game-changing addition to a broad contraceptive method mix.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

An overview of DMPA-SC: Injectable contraception that expands access and options

This DMPA-SC Advocacy Pack brief offers quick facts on the benefits of DMPA-SC; the product’s potential for empowering women and adolescent girls; the product’s availability; and how subcutaneous DMPA is different from intramuscular DMPA (DMPA-IM).

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

Common terms for DMPA injectable contraception

This DMPA-SC Advocacy Pack brief helps you understand the terms surrounding DMPA injectables to inform your messaging and communication.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

DMPA-SC self-injection: Advancing contraceptive access and use for women and girls

This DMPA-SC Advocacy Pack brief details the strong body of evidence and experience with self-injection of DMPA-SC, including how the practice can reduce access-related barriers, improve contraceptive continuation, and enhance women’s autonomy.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

Evidence at-a-glance: What we know about DMPA-SC, a novel injectable contraceptive

These DMPA-SC Advocacy Pack briefs outline existing evidence on DMPA-SC grouped into top-line messages featuring data from different countries. Several “spotlight” handouts on specific topics can be paired with the summary brief as needed. All handouts can be printed and distributed directly to decision-makers.

Institutional author(s): PATH
Publication date: 2023

DMPA-SC key facts: Answering questions and dispelling common myths

This DMPA-SC Advocacy Pack brief offers concise, evidence-based information to help answer common questions and dispel myths about injectable contraception.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

State of Self-Care Report

Progress and Potential of Self-Care: Taking Stock and Looking Ahead

The momentum around self-care is building through an array of self-care practices, policies, and interventions worldwide. This report aims to take stock of the SRH self-care field and document its progress. It is intended to provide a resource for global and national advocacy, to inform implementation of self-care guidelines, and to link the reader to evidence and learning exchanges. It includes case examples describing the process of introducing and scaling up DMPA-SC self-injection in Malawi and Nigeria.

Institutional author(s): Self-Care Trailblazer Group
Publication date: June, 2023

Introducing new self-care family planning methods: Lessons from DMPA-SC and the Caya diaphragm

This webinar held on February 23, 2022 was hosted by Expanding Effective Contraceptive Options (EECO) led by WCG Cares with PSI and the DMPA-SC Access Collaborative led by PATH in partnership with JSI. The discussion focused on the introduction and scale up of self-care family planning methods in sub-Saharan Africa, highlighting lessons and best practices from DMPA-SC scale-up and Caya® diaphragm pilot introductions in French-speaking West Africa. Presenters from Benin, Niger, and Senegal shared successes and challenges. This webinar was offered in French.

Institutional author(s): PATH, JSI, Population Services International (PSI), Association Béninoise pour le Marketing Social et la Communication pour la Santé, Expanding Effective Contraceptive Options
Publication date: February, 2022